Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Active immunisation against hepatitis A Age: Adult |
Dose: Intramuscular – First dose Note: At selected date |
|
Indication: Active immunisation against hepatitis A Age: Adult |
Dose: Intramuscular – Second dose Note: 6 months after first dose |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Active immunisation against hepatitis A Age: Children of 1 year of age |
Dose: Intramuscular – First dose: At selected date Note: Second dose: 6 months after first dose |
|
Indication: Active immunisation against hepatitis A Age: Children 12 months to 15 years |
Dose: Intramuscular – 0.5 ml Note: Second dose: 6 months after first dose |
Administration
- Give intramuscularly only
- Complete vaccination schedule
Side Effect
- Injection site tenderness (3-56%)
- erythema (1-22%)
- warmth (1-17%)
- swelling (9-11%)
- Irritability (11-36%)
- Anorexia (1-19%)
- Drowsiness (15-17%)
- Headache (1-16%)
- Fever More than 100.4 F (9-11%)
- URI (1-10%)
- Otitis media (8%)
- Rhinorrhea (6%)
- Diarrhea (1-6%)
- Cough (1-5%)
- Rash (1-5%)
- Weakness/fatigue (4%)
- Vomiting (1-4%)
- Fever More than 102 F (3%)
- Crying (2%)
- Hematoma
- Incr
- CPK
- Photophobia
- Vertigo
- Anaphylaxis
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Immunosuppressants (Cyclosporine, Tacrolimus, Mycophenolate, Azathioprine) (Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone), antineoplastics)
|
Reduced response to vaccination
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe immunodeficiency
|
Reduced vaccine effectiveness
|
|
Malignant disease under treatment
|
Impaired immune response
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep out of the reach and sight of children Store and transport at 2°C to 8°C. Protect from light
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.